The Institute for Genomic Research (TIGR) has completed the genome sequence of Streptococcus pneumoniae, a bacterium that causes serious infections such as pneumonia, meningitis, and otitis media. The study provides valuable insights into the bacterium's virulence factors and potential drug targets.
The complete genome of pneumococcus has been sequenced, revealing its genetic makeup and potential applications in treating the bacterium. The newly released genome contains 2,326 sequenced genes, providing a comprehensive model for researchers to study its virulence and develop new therapies.
A newly completed genomic sequence of E. coli O157:H7 reveals how these bacteria are armed with a wide range of genes that trigger illness. The study found large-scale genetic changes, including the ability for viruses to introduce virulent genes, making it harder to control public health threats.
The Joint Genome Institute (JGI) has produced high-quality draft sequences of 15 bacterial genomes in under a month, representing diverse organisms and a new approach to sequencing microbes. This data will be publicly available, providing scientists with immediate access to essential information for research.
Researchers have sequenced the Ureaplasma urealyticum genome, revealing a novel metabolic system and 652 genes with unknown functions. The discovery will aid in understanding how the bacterium causes disease and may lead to better treatments.
The E. coli genome, consisting of 4,639,221 base pairs, has been fully sequenced, revealing 1,333 known genes and 1,000 unknown functions. The completion of the genome paves the way for a similar analysis of human DNA.